Magen Darm Zentrum
Remscheid, Germany
Gastroenterologist in Remscheid, North Rhine-Westphalia
Rosenhügeler Str. 2, 42859 Remscheid
About Magen Darm Zentrum
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Pfizer
3
Arena Pharmaceuticals
2
Clinical Trials at Magen Darm Zentrum
During the past decade, Magen Darm Zentrum conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
2015-04-22
2018-10-31
Completed
2,565
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
2019-06-13
2022-02-16
Completed
433
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
2021-04-12
2025-01-31
Recruiting
225
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
2022-01-19
2025-08-14
Recruiting
318
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Magen Darm Zentrum"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Magen Darm Zentrum
According to Clinical.Site data, the most researched conditions in "Magen Darm Zentrum" are
"Ulcerative Colitis" (5 trials), "Crohn's Disease" (3 trials), "Crohn Disease" (1 trials) and "Inflammatory Bowel Diseases" (1 trials). Many other conditions were trialed in "Magen Darm Zentrum" in a lesser frequency.
Clinical Trials Intervention Types at Magen Darm Zentrum
Most popular intervention types in "Magen Darm Zentrum" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (4 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Magen Darm Zentrum
The vast majority of trials in "Magen Darm Zentrum" are
8 trials for "All" genders.
Clinical Trials Status at Magen Darm Zentrum
Currently, there are NaN active trials in "Magen Darm Zentrum".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Magen Darm Zentrum,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Magen Darm Zentrum, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".